Zusammenfassung
Das prämenstruelle Syndrom (PMS) tritt häufig bei jungen Frauen im gebärfähigen Alter auf, es kann aber auch erst zu Beginn der Perimenopause manifest werden. Etwa 5% der Patientinnen leiden unter einer schweren Form, der prämenstruellen dysphorischen Störung (PMDS). Aufgrund einer fehlenden einheitlichen pathophysiologischen Genese erfolgt die Behandlung symptomatisch in Form eines multikausalen Stufentherapiekonzeptes nach eingehender Diagnostik und Ausschluss anderer Erkrankungen. Neben einer Vielzahl an sowohl pharmakologischen als auch nichtmedikamentösen Strategien ist die Gabe von Vitamin B6 eine mögliche Option zur Linderung insbesondere der psychischen Beschwerden, die für die betroffenen Frauen oftmals eine größere Beeinträchtigung darstellen können als die körperlichen Symptome. Der vorliegende Beitrag erläutert die klinische Wirksamkeit von Vitamin B6 bei PMS aufgrund der aktuellen wissenschaftlichen Literatur.
Abstract
Premenstrual syndrome is common in young women but can also arise at the beginning of the perimenopausal phase. Approximately 5% of patients suffer from premenstrual dysphoric disorder (PMDD), a severe form of PMS. Due to the lack of a consistent pathophysiological etiology, treatment is symptomatic in terms of a multi-causal, stepwise treatment concept after exact diagnosis and exclusion of other diseases. In addition to a range of both pharmacological and non-pharmacological strategies, the administration of vitamin B6 is a potential option, particularly for alleviating psychic disorders, which often cause patients greater problems than physical disorders. This article highlights the clinical efficacy of vitamin B6 for premenstrual disorder on the basis of the current scientific literature.
This is a preview of subscription content, access via your institution.
Literatur
Bendich A (2000) The Potential for Dietary Supplements to Reduce Premenstrual Syndrome (PMS) Symptoms. J Am College Nutrition 19: 3–12
De Souza MC, Walker AF, Robinson PA, Bolland K (2000) A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Women Health Gender Based Med 9: 131–139
Dimmock PW, Wyatt KM, Jones PW, O’Brien PM (2000) Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356: 1131–1136
Endicott J, Amsterdam J, Eriksson E et al. (1999) Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gender Based Med 8: 663–679
Facchinetti F, Genazzani MD, Martignoni E et al. (1990) Neuroendocrine correlate of premenstrual syndrome. Psychoneuroendocrinology 15: 269
Feuerstein M, Shaw WS (2002) Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. J Reprod Med 47: 279–289
Fugh-Berman A, Kronenberg F (2003) Complementary and alternative medicine (CAM) in reproductive-age women: a review in randomized controlled trials. Reprod Toxicol 17: 137–152
Fryer CP, Kaspi SP, Fallon SK et al. (1999) Premenstrual dysphoric disorder: literature review. Arch Womens Mental Health 2: 1–27
Girman A, Lee R, Kligler B (2003) An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol 188: S56–S65
Halbreich U (2003) The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuriendocrinology 28: 55–99
Halbreich U, Endicott J (1981) Possible involvement of endorphine withdrawl or imbalance in specific premenstrual syndromes and postpartum depression. Med Hypotheses 7: 1045
Hvas A-M, Juul S, Bech P, NexØ E (2004) Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom 73: 340–343
Janiger O, Riffenburgh R, Kersh R (1972) Cross cultural study of premenstrual symptoms. Psychosomatics 13: 226
Kashanian M, Mazinani R, Jalalmanesh S (2007) Pyridoxine (vitamin B6) therapy for premenstrual syndrome. Int J Gynaecol Obstet 96: 43–44
Kendall KE, Schurr PP (1987) The effects of vitamin B6 supplementation on premenstrual symptoms. Obstet Gynecol 70: 145–149
Lauritzen C, Reuter HD, Repges R et al. (1997) Treatment of premenstrual tension syndrome with Vitex agnus castus controlles, double-blind study versus pyridoxine. Phytomedicine 4: 183–189
Lenzinger E, Diamant K, Vytiska-Binstorfer E, Kasper S (1997) Prämenstruelle dysphorische Störung (PMDS). Nervenarzt 68: 708–718
London RS, Bradley L, Chiamori NY (1991) Effect of nutritional supplement of premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study. J Am Coll Nutr 10: 494–499
Löffler G (2003) Vitamine. In Löffler G, Petrides P (Hrsg) Biochemie und Pathobiochemie. Springer, Berlin Heidelberg New York, S 741
Mishell DR (2005) Premenstrual disorders: epidemiology and disease burden. Am J Managed Care 11: 473–479
Proctor ML, Murphy PA (2001) Herbal and dietary therapies for primary and secondary dysmenorrhoea. The Cochrane Database of Systematic Review: Issue 2
Rapkin AJ, Edelmuth E, Chang LC et al. (1987) Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 70: 533–537
Rapkin AJ, Shoupe D, Reading A et al (1996) Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone. J Soc Gyn Invest 3: 93–98
Reid RL, Yen SSC (1981) Premenstrual syndrome. Am J Obstet Gynecol 139: 85–104
Saß Henning (1996) Diagnostisches und statistisches Manual psychischer Störungen. Hogrefe, Göttingen
Seippel L, Bäckström T (1998) Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. Jo Clinical Endocrinol Metabolism 83: 1988–1992
Steiner M, Macdougall M, Bown E (2003) The premenstrual symptoms screening tool (PSST) for clinicians. Arch Women Ment Health 6: 203–209
Steward A (1987) Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32: 435–441
Tulenheimo A, Laatikanen T, Salminen K (1987) Plasma ß-endorphin immunoreactivity in premenstrual tension. Br J Obstet Gynecol 94: 26
Villegas-Sala E (1997) Effect of vitamin B6 on the side effects of a low-dose combined oral contraceptive. Contraception 55: 245–248
Williams A, Cotter A, Sabina A et al. (2005) The role for vitamin B-6 as treatment for depression: a systematic review. Family Practice 22: 532–537
Williams MJ, Harris RI, Dean BC (1985) Controlled trial of pyridoxine in the premenstrual syndrome. J Int Med Res 13: 174–179
Wyatt KM, Dimmock PW, Jones PW, O’Brien PM (1999) Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. Br Medical J 318: 1375–1381
Wyatt KM, Dimmock PW, Jones PW et al. (2001) Efficacy of progesterone and progestogens in management of premenstrual syndrome: a systematic review. BJM 323: 776–780
Wyatt KM, Dimmock PW, Ismail KMK et al. (2004) The effectiveness of GnRHa with and without „add-back“ therapy in treating premenstrual syndrome: a meta analysis. Br J Obstet Gynaecol 111: 585–593
Zahradnik HP, Wetzka B, Schuth W (2000) Zyklusabhängige Befindlichkeitsstörungen der Frau. Gynäkologe 33: 225–238
Interessenskonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin: Erstellung eines wissenschaftlichen Gutachtens für Biokanol Pharma GmbH, Honorar an Universität Heidelberg.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reinhard-Hennch, B., Strowitzki, T. Vitamin B6 bei prämenstruellem Syndrom. Gynäkologische Endokrinologie 6, 87–93 (2008). https://doi.org/10.1007/s10304-008-0260-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10304-008-0260-y
Schlüsselwörter
- Prämenstruelles Syndrom (PMS)
- Prämenstruelle dysphorische Störung (PMDS)
- Depression
- Vitamin B6
- Pyridoxin
Keywords
- Premenstrual syndrome
- Late luteal phase dysphoric disorder
- Depression
- Vitamin B6
- Pyridoxine